KAKEN PHARMACEUTICAL - stock earnings
4521.T Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 1.4 billion JPY | 17.4 billion JPY |
| 2023Q4 | 2.6 billion JPY | 18.5 billion JPY |
| 2023Q3 | 1.6 billion JPY | 18.0 billion JPY |
| 2023Q2 | 2.5 billion JPY | 18.2 billion JPY |
| 2023Q1 | -3.7 billion JPY | 17.4 billion JPY |
| 2022Q4 | 3.2 billion JPY | 18.8 billion JPY |
| 2022Q3 | 3.1 billion JPY | 18.6 billion JPY |
| 2022Q2 | 2.9 billion JPY | 18.2 billion JPY |
4521.T Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 8.0 billion JPY | 72.0 billion JPY |
| 2023 | 5.4 billion JPY | 73.0 billion JPY |
| 2022 | 9.5 billion JPY | 76.0 billion JPY |
| 2021 | 13.4 billion JPY | 75.0 billion JPY |
| 2020 | 19.4 billion JPY | 89.2 billion JPY |
4521.T
Price: ¥3,619
Dividend Yield: 0.04%
Forward Dividend Yield: 4.36%
Payout Ratio: 190.52%
Dividend Per Share: 150.00 JPY
Earnings Per Share: 78.77 JPY
P/E Ratio: 37.18
Exchange: JPX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 131.9 billion
Average Dividend Frequency: 2
Years Paying Dividends: 24
DGR10: 9.04%
DGR20: 13.71%